Skip to main content

Table 1 Baseline characteristics of patient with Cryptococcal Meningitis Diagnosis between 2010 and 2017

From: Ambulatory induction phase treatment of cryptococcal meningitis in HIV integrated primary care clinics, Yangon, Myanmar

Characteristic Variable Total (N = 76)a
Demographics Age 35 (30, 38)
Male gender 48/76 (63%)
History Concurrent tuberculosis treatment 33/74 (45%)
Concurrent OI (e.g. oesophageal candidiasis, MAC) 27/76 (36%)
IRIS 25/75 (33%)
Symptoms Headache 47/64 (73%)
Fever 33/59 (56%)
Weight loss 31/60 (52%)
Altered mental state 58/76 (76%)
Signs Focal neurology 12/51 (24%)
Skin lesions 15/20 (75%)
Abnormal chest examination 5/63 (7.9%)
Investigations CD4 count- at time of CM 60.0 (31.0, 112.0)
Serum CrAG positive 33/39 (85%)
Split skin smear positive 16/31 (52%)
CSF Opening pressure > 20 cm 35/72 (54%)
CSF India Ink positive 50/70 (73%)
CSF CrAG positive 16/23 (70%)
  1. Abbreviations: CM cryptococcal meningitis, CrAG cryptococcal antigen, CSF cerebrospinal fluid, OI opportunistic infection, IRIS immune reconstitution inflammatory syndrome, MAC Mycobacterium avium complex
  2. an/N (%) or median (25th, 75th percentile)